Dosluoglu Hasan H, Lall Purandath, Cherr Gregory S, Harris Linda M, Dryjski Maciej L
Division of Vascular Surgery, VA Western NY Healthcare System, Buffalo, NY 14215, USA.
J Vasc Surg. 2009 Aug;50(2):305-15, 316.e1-2; discussion 315-6. doi: 10.1016/j.jvs.2009.01.004.
The goal of this study is to compare our results following open and endovascular infrainguinal revascularizations in patients >or=80 and <80 years old presenting with critical limb ischemia (CLI) and to determine if limb salvage (LS) attempt is justified in patients >or=80 with CLI, especially following endovascular interventions.
A retrospective analysis of 344 consecutive patients (399 limbs) who presented with CLI and underwent infrainguinal open or endovascular (EV) revascularizations between June 2001 and December 2007 was performed. Patients >or=80 (89 patients, 101 limbs) and <80 years old (255 patients, 298 limbs) were compared for demographics, characteristics, patency, limb salvage, sustained clinical success (preservation of limb, freedom from target extremity revascularization (TER), and resolution of symptoms), secondary clinical success (preservation of limb and resolution of symptoms), overall improvement (preservation of limb, improvement of symptoms), and survival.
Patients >or=80 were more likely to be nonambulatory and have coronary artery disease, whereas those <80 were more likely to have hypertension, hyperlipidemia, dialysis-dependence, active tobacco abuse, and taking beta-blockers. Primary amputation rates were similar between two groups (<80 vs >or=80, 6.7% vs 8.1%, P = .530). Perioperative mortality was significantly worse in >or=80 group in the open-treated group (16.2% vs 2.9%, P = .009), whereas it was similar in EV-treated patients (3.1% vs 0.6%, P = .197). The patency rates were similar between groups, however, LS was significantly better in >or=80 EV-treated patients than <80 group, whereas it was similar between groups in open-treated patients. Sustained clinical success, secondary clinical success, and overall improvement rates were similar between age groups. Endovascular-treated patients in >or=80 had significantly better overall improvement than those who were treated by open revascularization (24-month overall improvement 83% +/- 5% vs 61% +/- 9%, P = .043). Multivariate analysis showed diabetes, infrapopliteal intervention, presence of gangrene, nonambulatory status, dialysis-dependence, and runoff status being associated with limb loss whereas age being >/= or <80 was not. Age, coronary artery disease, chronic obstructive pulmonary disease, nonambulatory status, and dialysis-dependence were found to be independently associated with decreased survival.
Our results suggest that revascularization in patients >/=80 with CLI is justified, especially when an endovascular intervention can be accomplished. Although limb salvage following endovascular interventions were better in the >/=80 group, sustained clinical success, and secondary clinical success rates were similar following open and endovascular interventions in both age groups. Open procedures carry a high perioperative mortality in the >/=80 age group and should be avoided if possible.
本研究的目的是比较年龄≥80岁和<80岁的严重肢体缺血(CLI)患者接受开放性和血管腔内腹股沟下血管重建术后的结果,并确定对于年龄≥80岁的CLI患者,尤其是在接受血管腔内干预后,尝试保肢(LS)是否合理。
对2001年6月至2007年12月期间连续344例(399条肢体)出现CLI并接受腹股沟下开放性或血管腔内(EV)血管重建术的患者进行回顾性分析。比较年龄≥80岁(89例患者,101条肢体)和<80岁(255例患者,298条肢体)患者的人口统计学、特征、通畅率、保肢情况、持续临床成功(肢体保留、无需靶肢体血管重建(TER)以及症状缓解)、二次临床成功(肢体保留和症状缓解)、总体改善情况(肢体保留、症状改善)以及生存率。
年龄≥80岁的患者更可能无法行走且患有冠状动脉疾病,而年龄<80岁的患者更可能患有高血压、高脂血症、依赖透析、有主动吸烟习惯且正在服用β受体阻滞剂。两组的一期截肢率相似(<80岁组与≥80岁组,6.7%对8.1%,P = 0.530)。在开放性治疗组中,年龄≥80岁组的围手术期死亡率显著更高(16.2%对2.9%,P = 0.009),而在接受EV治疗的患者中则相似(3.1%对0.6%,P = 0.197)。两组的通畅率相似,然而,年龄≥80岁接受EV治疗的患者的保肢情况显著优于<80岁组,而在开放性治疗的患者中两组相似。各年龄组的持续临床成功率、二次临床成功率和总体改善率相似。年龄≥80岁接受血管腔内治疗的患者的总体改善情况显著优于接受开放性血管重建术的患者(24个月总体改善率83%±5%对61%±9%,P = 0.043)。多因素分析显示,糖尿病、腘动脉以下干预、坏疽的存在、无法行走状态、依赖透析以及流出道状态与肢体丢失相关,而年龄≥80岁或<80岁则无关。年龄、冠状动脉疾病、慢性阻塞性肺疾病、无法行走状态和依赖透析被发现与生存率降低独立相关。
我们的结果表明,对于年龄≥80岁的CLI患者进行血管重建是合理的,尤其是当可以完成血管腔内干预时。尽管年龄≥80岁组在血管腔内干预后的保肢情况更好,但两个年龄组在开放性和血管腔内干预后的持续临床成功率和二次临床成功率相似。在年龄≥80岁组中,开放性手术的围手术期死亡率较高,应尽可能避免。